Insider: Lee Jennifer Kayden EVP, Head of North America - RHYTHM PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 5,858 | 0 | 5,858 |
| Value | $580,762.12 | $0.00 | $580,762.12 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/19/2025 | DDS | 2,035 | Direct | COM | $57.22 | $116,442.70 | 5,858 |
| 02/13/2025 | DDS | 1,205 | Direct | COM | $58.00 | $69,890.00 | 2,393 |
| 02/12/2025 | DDS | 600 | Direct | COM | $56.39 | $33,834.00 | 4,813 |
| 02/12/2025 | DDS | 1,205 | Direct | COM | $56.39 | $67,949.95 | 3,598 |
| 02/12/2025 | DDS | 10 | Direct | COM | $56.41 | $564.10 | 4,803 |
| 02/11/2025 | DDS | 1,023 | Direct | COM | $57.51 | $58,832.73 | 5,417 |
| 02/11/2025 | DDS | 4 | Direct | COM | $57.50 | $230.00 | 5,413 |
| 02/10/2025 | DDS | 1,894 | Direct | COM | $58.39 | $110,595.96 | 6,704 |
| 02/10/2025 | DDS | 2,295 | Direct | COM | $59.34 | $136,187.14 | 4,409 |
| 02/05/2025 | DDS | 1,733 | Direct | COM | $60.08 | $104,120.55 | 2,305 |
| 02/05/2025 | DDS | 200 | Direct | COM | $61.95 | $12,390.00 | 972 |
| 02/05/2025 | DDS | 1,133 | Direct | COM | $61.01 | $69,129.66 | 1,172 |
| 02/04/2025 | DDS | 1,447 | Direct | COM | $59.43 | $85,995.21 | 4,038 |
| 11/11/2024 | DDS | 17,540 | Direct | COM | $66.95 | $1,174,274.94 | 12,242 |
| 11/11/2024 | DDS | 38,051 | Direct | COM | $65.68 | $2,499,048.89 | 29,782 |
| 11/11/2024 | DDS | 11,070 | Direct | COM | $67.56 | $747,872.60 | 1,172 |
| 11/11/2024 | DDS | 200 | Direct | COM | $68.43 | $13,686.00 | 972 |
| 03/20/2024 | DDS | 9,169 | Direct | COM | $38.22 | $350,439.18 | 15,918 |
| 03/20/2024 | DDS | 9,066 | Direct | COM | $39.33 | $356,565.78 | 6,852 |
| 03/19/2024 | DDS | 15,515 | Direct | COM | $39.22 | $608,498.30 | 25,087 |
| 02/13/2024 | DDS | 615 | Direct | COM | $49.83 | $30,645.45 | 6,852 |
| 02/12/2024 | DDS | 1,023 | Direct | COM | $51.38 | $52,561.74 | 7,467 |
| 02/01/2024 | DDS | 1,492 | Direct | COM | $45.06 | $67,229.52 | 3,021 |
| 11/14/2023 | DDS | 13,677 | Direct | COM | $32.01 | $437,818.55 | 0 |
| 11/09/2023 | DDS | 1,719 | Direct | COM | $27.37 | $47,051.09 | 3,366 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research